Cholinesterase Inhibitors in Non-age Related Neurodegenerative Dementias
International Neuropsychiatric Disease Journal · pp. 13–18 · Published 16 Sep 2014
10.9734/INDJ/2015/12752Abstract
Aims: Dementia is common among the elderly but it can also affect the younger age group. Cholinesterase inhibitors (ChEI) in Alzheimer Dementia (AD) are extensively studied and widely used. This case report aims to illustrate the usefulness of ChEIs in other non–age related neurodegenerative dementias apart from AD. Presentation of Cases: Four cases in which ChEIs was found to be useful in improving the cognition following Traumatic Brain Injury, Nipah Encephalitis, Cerebral Malaria and Meningo-encephalitis. All the four cases were prescribed ChEIs and were followed up in a Memory Clinic. All of them showed substantial and sustained cognitive improvement. Discussion: Traumatic brain injury causes axonal swelling with accumulation of beta-amyloid and alters progranulin metabolism. Nipah Virus infection of brain parenchyma causes vasculitis, endothelial damage and micro-infarction. While in cerebral malaria, infected and non-infected erythrocytes within the cerebral vessels reduces microvascular flow and initiates inflammatory cascade. Infective encephalitis causes neurotoxin production and inflammatory process. These pathological processes reduce cerebral neurotransmitters concentration including acetylcholine. Cholinesterase inhibitors enhance cognitive function by increasing the amount of acetylcholine at the neuronal synaptic cleft. This clinical significance may be extended to patients with cognitive impairments other than AD. Conclusion: This report highlights the usefulness of ChEI in non–age related neurodegenerative dementias. Off label use of ChEI in non-AD dementias warrant proper clinical trials to recommend for clinical practice.
References (18)
- 1 Rivastigmine for Dementia Associated with Parkinson's Disease [DOI]
- 2 Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study [DOI]
- 3 A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease [DOI]
- 4 Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia [DOI]
- 5 Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children [DOI]
- 6 Etiology of Encephalitis in Australia, 1990–2007 [DOI]
- 7 Mycoplasma pneumoniae and central nervous system complications: A review [DOI]
- 8 Neuropsychiatric Sequelae of Nipah Virus Encephalitis [DOI]
- 9 Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials [DOI]
- 10 Road Traffic Injuries: Social Change and Development [DOI]
- 11 Cholinesterase inhibitors: beyond Alzheimer’s disease [DOI]
- 12 Rethinking cerebral malaria pathology [DOI]
- 13 Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. [DOI]
- 14 Nipah virus encephalitis [DOI]
- 15 Trend of hospital utilization for encephalitis [DOI]
- 16 The Changes of Cortical Metabolism Associated With the Clinical Response to Donepezil Therapy in Traumatic Brain Injury [DOI]
- 17 Traumatic Brain Injury May Increase the Risk for Frontotemporal Dementia through Reduced Progranulin [DOI]
- 18 Cognitive Outcome in Acute Sporadic Encephalitis [DOI]
Cited by 0
No indexed citations yet.
Related research
- Efficacy and Tolerability of MlC601 in Patients with Mild to Moderate Alzheimer Disease who were Unable to Tolerate or Failed to Benefit from Treatment with Rivastigmine — shares topic coverage
- Health Economic Evaluations for Alzheimer’s Disease: Pathophysiology, Diagnosis and Pharmacological Approaches — shares topic coverage
Article metrics
Real usage data collected on this platform.
16
Page views
0
PDF downloads
1
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.